Back to companies
NewAmsterdam Pharma Co N.V.
NAMSNLNASDAQPharmaceuticals & HealthcareNewAmsterdam Pharma Co N.V.
Revenue
$22.5mn
YoY -50.6%
Operating income
-$225.7mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API